Drugs for the HeartLionel H. Opie This pocket-sized reference is a practitioner's guide to the complexities of modern cardiovascular drug therapy. The reader should find coverage of all aspects of current cardiac drug usage, with instructional diagrams and 1994 references. |
Contents
BBlocking Agents | 1 |
Nitrates | 19 |
Calcium Channel Antagonists Slow Channel | 34 |
Copyright | |
8 other sections not shown
Common terms and phrases
ACE inhibitors action activity acute added agents amiodarone angina antiarrhythmic anticoagulation artery aspirin atrial flutter avoid B-blockade B-blockers benefit block blood calcium antagonists captopril cardiac Cardiol cause chronic Circulation Class clinical combination congestive heart failure Contraindications coronary daily decrease depression digitalis digoxin diltiazem disease disopyramide diuretics dose drugs early effect efficacy enalapril especially et al excess flecainide frequently function furosemide given half-life heart failure hemodynamic hydralazine hypertension hypotension improve increase indications infusion inhibition initial inotropic effect interactions less levels lidocaine limited long-term mechanism myocardial infarction needed nifedipine nitrates nitroglycerin Opie oral patients percent peripheral Pharmacokinetics plasma platelet possible potassium potential pressure prevention prolonged propranolol pulmonary quinidine reduced reference renal response risk severe side-effects systemic Table tachycardia therapeutic therapy thiazide tion tolerance toxicity treatment trial usually vascular vasodilator ventricular ventricular arrhythmias verapamil